Admission levels of UCH-L1 have proven utility as a biomarker of BBB dysfunction, neurologic deficits at 24 months, memory impairment over time in cerebral malaria, and attention deficits over time in severe malarial anaemia. This evidence concerns the gene UCHL1 and memory impairment.